Sector: MedicalACORDA THERAPEUTICS (NASDAQ: ACOR)
Headlines
- Acorda Therapeutics to Present at the 21st Annual Piper Jaffray Health Care Conference
Nov 24, 2009 07:00 AM | ACOR, PJC
- Acorda Therapeutics to Present at the Lazard Capital Markets 6th Annual Healthcare Conference
Nov 16, 2009 10:02 AM | ACOR
- Big Pharma And Biotech - Industry Outlook
Nov 09, 2009 06:03 PM | ABT, ACL, ACOR, ALKS, AZN, BBI
- Acorda Therapeutics to Host Conference Call to Report Third Quarter 2009 Financial Results on November 3, 2009
Oct 27, 2009 07:00 AM | ACOR
- Acorda Therapeutics Announces Extension of Fampridine-SR PDUFA Goal Date to January 22, 2010
Oct 22, 2009 06:00 AM | ACOR
- More New 2009 Highs!
Oct 19, 2009 08:27 PM | ACOR, AIG, GS, NTRI, RMBS
- This Fall Will Be Crazy For These Biotech Stocks
Oct 16, 2009 02:55 PM | ACOR, AMGN, CADX, GTXI, THRX, XNPT
- StockSource.us Reports on MNDP -- Pioneering Surveillance Technologies
Oct 16, 2009 02:00 AM | ACOR
- Blue Chips Continue Rally, But Nasdaq 100 Lags
Oct 15, 2009 06:28 PM | ACOR, DNDN, GS, VNDA
- A Positive FDA Panel Outcome for Acorda Therapeutics (NASDAQ: ACOR)
Oct 15, 2009 10:24 AM | ACOR, BIIB
- Citigroup, Nokia, Capital 1, Safeway big movers
Oct 15, 2009 07:10 PM | ACOR, C, COF, MANH, MNI, NOK
- Biogen Idec: Shifting Its Multiple Sclerosis Pipeline
Jul 02, 2009 10:59 AM | ACOR
- AIG, General Mills, MetroPCS are big movers
Jul 01, 2009 04:56 PM | ACOR, AIG, BIIB, FRPT, GIS, MYGN
- Acorda shares fall on Biogen partnership
Jul 01, 2009 12:54 PM | ACOR, BIIB
- Acorda Therapeutics Reports Third Quarter 2009 Financial Results
Nov 03, 2009 06:51 AM | ACOR
- PicksThatMove.Com Announces Investment Opinion Hot Stocks on NVNC, MPG, ACOR, KNA and ROYL
Oct 16, 2009 11:52 AM | ACOR, MPG, SCI
- Acorda Therapeutics Names Ruhi Kahn as Vice President, Business Development
Aug 05, 2009 07:02 AM | ACOR
- Acorda Therapeutics Reports Second Quarter 2009 Financial Results
Aug 04, 2009 06:09 AM | ACOR
- Acorda Therapeutics to Host Conference Call to Report Second Quarter 2009 Financial Results on August 4, 2009
Jul 28, 2009 07:09 AM | ACOR
- Biogen Idec Reports Second Quarter 2009 Results
Jul 16, 2009 07:53 AM | ACOR, BIIB, ELN
- Biogen Idec and Acorda Therapeutics Announce Collaboration Agreement to Develop and Commercialize MS Therapy Fampridine-SR in Markets Outside the U.S.
Jul 01, 2009 06:05 AM | ACOR, BIIB
- Acorda Therapeutics Announces Eligibility of Fampridine-SR for Centralized Review in Europe
Jun 08, 2009 07:09 AM | ACOR
- Acorda Therapeutics Reports First Quarter 2009 Financial Results
May 06, 2009 06:51 AM | ACOR
- Acorda Therapeutics Announces FDA Acceptance of Fampridine-SR New Drug Application for Filing
May 06, 2009 06:08 AM | ACOR
- Form 4 ACORDA THERAPEUTICS INC For: Aug 12 Filed by: Randall Lorin (10K)
Aug 13, 2009 05:33 PM
- Form 4 ACORDA THERAPEUTICS INC For: Jun 22 Filed by: YOUNG WISE (10K)
Jun 23, 2009 05:42 PM
- Form 4 SMITH IAN F For: Jun 22 (10K)
Jun 23, 2009 05:41 PM
- Form 4 ACORDA THERAPEUTICS INC For: Jun 22 Filed by: PANEM SANDRA PHD (10K)
Jun 23, 2009 05:39 PM
- Form 4 ACORDA THERAPEUTICS INC For: Jun 22 Filed by: Randall Lorin (10K)
Jun 23, 2009 05:38 PM
- Form 4 ACORDA THERAPEUTICS INC For: Jun 22 Filed by: Kelley John P (10K)
Jun 23, 2009 05:35 PM
- Form 4 ACORDA THERAPEUTICS INC For: Jun 22 Filed by: Greene Barry E (10K)
Jun 23, 2009 05:33 PM
- Form 4 ACORDA THERAPEUTICS INC For: Mar 02 Filed by: LAWRENCE DAVID (10K)
Mar 04, 2009 04:55 PM
- Form 4 ACORDA THERAPEUTICS INC For: Mar 02 Filed by: Blight Andrew (10K)
Mar 04, 2009 04:50 PM
- Form 4 ACORDA THERAPEUTICS INC For: Feb 26 Filed by: PANEM SANDRA PHD (10K)
Feb 26, 2009 04:25 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
ACOR
|
Compare to S&P
|
| YTD |
16.53 %
|
-3.56 %
|
| 4 Weeks |
2.58 %
|
1.47 %
|
| 12 Weeks |
5.38 %
|
-0.65 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 16.13 %
|
|
EPS Growth in Last Year: 1.89 %
|
|
Sales Growth in Last Quarter: 21.23 %
|
|
Sales Growth in Last Quarter: 22.04 %
|
|
